Since 2006, Eurofarma has publicly disclosed its financial results and a summary of its annual initiatives.
To guide the content reported in its publications, the company incorporated information derived from its results and from consultations with its key stakeholders, which identified the topics they considered important to be addressed. Eurofarma also took into account its strategic planning aligned with Vision 2027, which will guide the company over the next five years, as well as the trends and challenges of the pharmaceutical sector.
Eurofarma’s 2026 Integrated Sustainability Report, with base year 2025, was prepared in accordance with the Global Reporting Initiative (GRI) Standards and CPC 09 Guidance – Integrated Reporting, and was assured by independent audit firm KPMG. It also includes SASB (Sustainability Accounting Standards Board) indicators for the Biotechnology and Pharmaceutical industries. The content provides a clear, data-driven account of topics that are relevant to society, employees, and the market.
We wish you an enjoyable reading.